NasdaqCM - Nasdaq Real Time Price USD

Profound Medical Corp. (PROF)

4.9900

+0.2800

+(5.94%)

At close: May 19 at 4:00:00 PM EDT

5.0900

+0.10

+(2.00%)

Pre-Market: 9:00:23 AM EDT

Arun Menawat Bought 2.1% More Shares In Profound Medical

Even if it's not a huge purchase, we think it was good to see that Arun Menawat, the Chairman of the Board & CEO of...

Simply Wall St. 2 days ago

PROF
+5.94%
Profound Medical Annual General and Special Meeting of Shareholders Voting Results

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders that was held today (the “Meeting”). A total of 20,587,011 common shares, representing 68.5% of the common shares outstanding, were represented in person and by proxy at the Meeting. All of the matters put forward before the shareholders, as set out in the Company’s management

GlobeNewswire 5 days ago

PROF
+5.94%
Profound Medical First Quarter 2025 Earnings: Misses Expectations

Profound Medical ( TSE:PRN ) First Quarter 2025 Results Key Financial Results Revenue: US$2.62m (up 37% from 1Q 2024...

Simply Wall St. 10 days ago

PROF
+5.94%
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...

Profound Medical Corp (PROF) reports an 82% revenue increase and improved gross margins, while navigating increased expenses and strategic shifts.

GuruFocus.com 11 days ago

PROF
+5.94%
Profound Medical Announces First Quarter 2025 Financial Results

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the first quarter ended March 31, 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. gener

GlobeNewswire 11 days ago

PROF
+5.94%
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre. The

GlobeNewswire 19 days ago

PROF
+5.94%
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer – – TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery to baseline activities and overall health – TORONTO, April 29, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapie

GlobeNewswire 21 days ago

PROF
+5.94%
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the

GlobeNewswire last month

PROF
+5.94%
With 56% institutional ownership, Profound Medical Corp. (TSE:PRN) is a favorite amongst the big guns

Key Insights Institutions' substantial holdings in Profound Medical implies that they have significant influence over...

Simply Wall St. last month

PROF
+5.94%
Profound Medical AUA 2025 Investor Event Agenda

TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today additional details regarding its hybrid (in-person and virtual) investor event taking place on Monday, April 28, 2025, during the American Urological Association’s (“AUA”) Annual Meeting. The event will be held at the Wa

GlobeNewswire last month

PROF
+5.94%
Save the Date: Profound Medical to Host Investor Event at AUA 2025

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will host a hybrid (in-person and virtual) investor event on Monday, April 28, 2025, during the American Urological Association’s (“AUA”) Annual Meeting in Las Vegas, NV, from 3:30 p.m. to 5:00 p.m. Pacific Time (6:30 p.m. to 8:00 p.m.

GlobeNewswire last month

PROF
+5.94%
Insider Spends US$144k Buying More Shares In Profound Medical

Potential Profound Medical Corp. ( TSE:PRN ) shareholders may wish to note that the Chairman of the Board & CEO, Arun...

Simply Wall St. last month

PROF
+5.94%
Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ...

Profound Medical Corp (PROF) reports a 108% revenue growth and a significant reduction in net loss, while navigating challenges in site expansion and reimbursement strategies.

GuruFocus.com 2 months ago

PROF
+5.94%
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the fourth quarter and full year ended December 31, 2024. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.

GlobeNewswire 2 months ago

PROF
+5.94%
Profound Medical (TSE:PRN) adds CA$31m to market cap in the past 7 days, though investors from five years ago are still down 39%

Profound Medical Corp. ( TSE:PRN ) shareholders should be happy to see the share price up 11% in the last week. But...

Simply Wall St. 2 months ago

PROF
+5.94%
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business dev

GlobeNewswire 3 months ago

PROF
+5.94%
Profound Medical Corp.'s (TSE:PRN) Profit Outlook

We feel now is a pretty good time to analyse Profound Medical Corp.'s ( TSE:PRN ) business as it appears the company...

Simply Wall St. 3 months ago

PROF
+5.94%
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that its scheduled presentation time at the 43rd Annual J.P. Morgan Healthcare Conference has been changed to 9:00 a.m. Pacific Time on Thursday, January 16, 2025. The presentation will be broadcast live and archived on t

GlobeNewswire 4 months ago

PROF
+5.94%
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

– Fourth quarter revenue growth estimated at 105% to 110% year-over-year – – Company to start reporting in accordance with U.S. GAAP and filing with the SEC on U.S. domestic forms – – Profound reminds investors that it is scheduled to present at JPM 2025 on January 16th at 11:15 a.m. PT – TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision

GlobeNewswire 4 months ago

PROF
+5.94%
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 11:15 a.m. Pacific Time in San Francisco, CA. The presentation will be

GlobeNewswire 4 months ago

PROF
+5.94%

Performance Overview

Return	PROF	S&P/TSX Composite index (^GSPTSE)
YTD	-29.22%	+5.49%
1-Year	-39.81%	+15.61%
3-Year	-29.32%	+28.69%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Profound Medical Corp. (PROF)

Arun Menawat Bought 2.1% More Shares In Profound Medical

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

Profound Medical First Quarter 2025 Earnings: Misses Expectations

Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...

Profound Medical Announces First Quarter 2025 Financial Results

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

With 56% institutional ownership, Profound Medical Corp. (TSE:PRN) is a favorite amongst the big guns

Profound Medical AUA 2025 Investor Event Agenda

Save the Date: Profound Medical to Host Investor Event at AUA 2025

Insider Spends US$144k Buying More Shares In Profound Medical

Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ...

Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

Profound Medical (TSE:PRN) adds CA$31m to market cap in the past 7 days, though investors from five years ago are still down 39%

Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

Profound Medical Corp.'s (TSE:PRN) Profit Outlook

Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Performance Overview